$EXPO
EXPONENT INC

2022 Q4 Form 10-Q Financial Statement

#000095017022022200 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2021 Q4
Revenue $127.4M $116.4M
YoY Change 9.41% 17.98%
Cost Of Revenue $14.77M $7.938M
YoY Change 86.02% 52.65%
Gross Profit $112.6M $108.5M
YoY Change 3.8% 16.01%
Gross Profit Margin 88.41% 93.18%
Selling, General & Admin $83.02M $70.28M
YoY Change 18.12% 4.27%
% of Gross Profit 73.73% 64.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.855M $1.645M
YoY Change 12.77% -3.24%
% of Gross Profit 1.65% 1.52%
Operating Expenses $90.55M $76.35M
YoY Change 18.61% 4.44%
Operating Profit $22.04M $32.12M
YoY Change -31.4% 57.39%
Interest Expense $1.262M $13.00K
YoY Change 9607.69% -95.67%
% of Operating Profit 5.73% 0.04%
Other Income/Expense, Net $7.222M $257.0K
YoY Change 2710.12% -93.44%
Pretax Income $30.52M $32.39M
YoY Change -5.77% 31.46%
Income Tax $7.995M $7.815M
% Of Pretax Income 26.2% 24.13%
Net Earnings $22.52M $24.57M
YoY Change -8.34% 35.89%
Net Earnings / Revenue 17.69% 21.11%
Basic Earnings Per Share $0.47
Diluted Earnings Per Share $0.44 $460.9K
COMMON SHARES
Basic Shares Outstanding 50.64M 52.62M
Diluted Shares Outstanding 53.31M

Balance Sheet

Concept 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.5M $254.8M
YoY Change -36.63% 22.67%
Cash & Equivalents $161.5M $297.7M
Short-Term Investments $25.00M
Other Short-Term Assets $17.59M $18.74M
YoY Change -6.15% 70.35%
Inventory
Prepaid Expenses
Receivables $170.1M $139.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $349.2M $452.8M
YoY Change -22.88% 37.79%
LONG-TERM ASSETS
Property, Plant & Equipment $65.54M $59.97M
YoY Change 9.28% -25.5%
Goodwill $8.607M $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.006M $1.521M
YoY Change 31.89% -98.7%
Total Long-Term Assets $237.5M $231.0M
YoY Change 2.83% 12.07%
TOTAL ASSETS
Total Short-Term Assets $349.2M $452.8M
Total Long-Term Assets $237.5M $231.0M
Total Assets $586.7M $683.7M
YoY Change -14.2% 27.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.642M $21.44M
YoY Change -59.7% 15.28%
Accrued Expenses $20.47M $92.78M
YoY Change -77.93% 35.65%
Deferred Revenue $18.83M $19.76M
YoY Change -4.7%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $159.0M $153.0M
YoY Change 3.95% 58.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.355M $2.886M
YoY Change -18.4% -96.97%
Total Long-Term Liabilities $2.355M $2.886M
YoY Change -18.4% -96.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $159.0M $153.0M
Total Long-Term Liabilities $2.355M $2.886M
Total Liabilities $265.9M $266.7M
YoY Change -0.29% 39.26%
SHAREHOLDERS EQUITY
Retained Earnings $528.8M $478.4M
YoY Change 10.54%
Common Stock $301.1M $281.5M
YoY Change 6.96%
Preferred Stock
YoY Change
Treasury Stock (at cost) $505.5M $340.8M
YoY Change 48.34%
Treasury Stock Shares $15.06M $13.59M
Shareholders Equity $320.8M $417.1M
YoY Change
Total Liabilities & Shareholders Equity $586.7M $683.7M
YoY Change -14.2% 27.87%

Cashflow Statement

Concept 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income $22.52M $24.57M
YoY Change -8.34% 35.89%
Depreciation, Depletion And Amortization $1.855M $1.645M
YoY Change 12.77% -3.24%
Cash From Operating Activities $40.57M $24.93M
YoY Change 62.76% -11.61%
INVESTING ACTIVITIES
Capital Expenditures $2.935M -$1.191M
YoY Change -346.43% -25.56%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$25.00M
YoY Change -100.0% -278.55%
Cash From Investing Activities -$2.935M -$26.19M
YoY Change -88.79% -311.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.42M -8.769M
YoY Change 189.9% -5.71%
NET CHANGE
Cash From Operating Activities 40.57M 24.93M
Cash From Investing Activities -2.935M -26.19M
Cash From Financing Activities -25.42M -8.769M
Net Change In Cash 12.21M -10.03M
YoY Change -221.76% -132.05%
FREE CASH FLOW
Cash From Operating Activities $40.57M $24.93M
Capital Expenditures $2.935M -$1.191M
Free Cash Flow $37.64M $26.12M
YoY Change 44.1% -12.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
34994000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000851520
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Document Type
DocumentType
10-Q
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
650
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-18655
dei Entity Registrant Name
EntityRegistrantName
EXPONENT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0218904
dei Entity Address Address Line1
EntityAddressAddressLine1
149 COMMONWEALTH DRIVE
dei Entity Address City Or Town
EntityAddressCityOrTown
MENLO PARK
dei Local Phone Number
LocalPhoneNumber
326-9400
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
EXPO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50638229
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148443000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297687000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6157000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4423000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166014000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139861000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18055000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15214000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
332512000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
452762000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64289000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59971000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18088000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14370000
CY2022Q3 us-gaap Goodwill
Goodwill
8607000
CY2021Q4 us-gaap Goodwill
Goodwill
8607000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
50501000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46546000
CY2022Q3 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
83722000
CY2021Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
99962000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1284000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1521000
CY2022Q3 us-gaap Assets
Assets
559003000
CY2021Q4 us-gaap Assets
Assets
683739000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
31825000
expo Revenue From Reimbursement
RevenueFromReimbursement
22249000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24504000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
84938000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103552000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15791000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19762000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5363000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5164000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
137917000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152982000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2639000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2886000
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
85453000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
100999000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13194000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9807000
CY2022Q3 us-gaap Liabilities
Liabilities
239203000
CY2021Q4 us-gaap Liabilities
Liabilities
266674000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
66000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
298589000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
281419000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-5136000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1983000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
518631000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
478370000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
14918000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
13591000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
492350000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
340807000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
319800000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
559003000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
683739000
CY2022Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
115143000
CY2021Q4 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
108467000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
351231000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
330514000
CY2022Q3 expo Revenue From Reimbursement
RevenueFromReimbursement
12036000
CY2021Q4 expo Revenue From Reimbursement
RevenueFromReimbursement
7938000
expo Revenue From Reimbursement
RevenueFromReimbursement
34707000
CY2021Q4 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8017000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127179000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116405000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385938000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
352763000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
62779000
CY2021Q4 us-gaap Labor And Related Expense
LaborAndRelatedExpense
64138000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
189982000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
210491000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8822000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
25742000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
23848000
CY2022Q3 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
12036000
CY2021Q4 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
7938000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
34707000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
22249000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6729000
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4193000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16700000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10626000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
90366000
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
84286000
us-gaap Operating Expenses
OperatingExpenses
267131000
us-gaap Operating Expenses
OperatingExpenses
267214000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36813000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
32119000
us-gaap Operating Income Loss
OperatingIncomeLoss
118807000
us-gaap Operating Income Loss
OperatingIncomeLoss
85549000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
638000
CY2021Q4 us-gaap Investment Income Net
InvestmentIncomeNet
13000
us-gaap Investment Income Net
InvestmentIncomeNet
834000
us-gaap Investment Income Net
InvestmentIncomeNet
54000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3975000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
257000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17926000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11579000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3337000
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
270000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17092000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11633000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33476000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32389000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
101715000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
97182000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9034000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7815000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21909000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16360000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24442000
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
24574000
us-gaap Net Income Loss
NetIncomeLoss
79806000
us-gaap Net Income Loss
NetIncomeLoss
80822000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51492000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52618000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51934000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52597000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52008000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53312000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52489000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53316000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.72
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24442000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
24574000
us-gaap Net Income Loss
NetIncomeLoss
79806000
us-gaap Net Income Loss
NetIncomeLoss
80822000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1493000
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-266000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3153000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-55000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22949000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24308000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
76653000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
80702000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1070000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5939000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
111843000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1660000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10200000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12904000
us-gaap Dividends
Dividends
25737000
us-gaap Net Income Loss
NetIncomeLoss
55364000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
337494000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
557000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53237000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70378000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1999000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
30783000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1493000
CY2022Q3 us-gaap Dividends
Dividends
12416000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24442000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
319800000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1023000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5676000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7000000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
211000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7637000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15666000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4000
us-gaap Dividends
Dividends
21856000
us-gaap Net Income Loss
NetIncomeLoss
56248000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
387767000
CY2021Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
518000
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1135000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1840000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-266000
CY2021Q4 us-gaap Dividends
Dividends
10579000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
24574000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
404989000
us-gaap Profit Loss
ProfitLoss
79806000
us-gaap Profit Loss
ProfitLoss
80822000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5224000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4943000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
11000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2112000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1197000
us-gaap Share Based Compensation
ShareBasedCompensation
16072000
us-gaap Share Based Compensation
ShareBasedCompensation
15239000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3955000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2020000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28265000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33671000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7583000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4878000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
132000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
472000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5140000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5784000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11211000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3053000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3971000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
392000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
142195000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9108000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5437000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
55000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9108000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14569000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12904000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15666000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1627000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2675000
us-gaap Payments Of Dividends
PaymentsOfDividends
37084000
us-gaap Payments Of Dividends
PaymentsOfDividends
32775000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-190556000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-52766000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2817000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-149244000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32260000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197525000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148443000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229785000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6343000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14215000
CY2022Q3 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
6996000
CY2021Q4 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
1219000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
18040000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
9923000
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
146373000
CY2022Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
94502000
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
94502000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
210923000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
110379000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51492000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52618000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51934000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52597000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52008000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53312000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52489000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53316000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
94579000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
109342000
CY2022Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
94502000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2022Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-4925000
CY2021Q4 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-258000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-20884000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
9997000
us-gaap Income Taxes Paid
IncomeTaxesPaid
24349000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16481000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10200000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7637000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
846000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
368000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8090000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
792000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6157000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4423000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166014000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139861000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4423000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2112000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
378000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6157000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
127179000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116405000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
385938000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
352763000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
36813000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
32119000
us-gaap Operating Income Loss
OperatingIncomeLoss
118807000
us-gaap Operating Income Loss
OperatingIncomeLoss
85549000
CY2022Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2090000
CY2021Q4 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1398000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
9541000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
5203000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1723000
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1645000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5224000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4943000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1518000
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1566000
us-gaap Operating Lease Payments
OperatingLeasePayments
5083000
us-gaap Operating Lease Payments
OperatingLeasePayments
5381000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1413000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5885000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4178000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3296000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3084000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2589000
CY2022Q3 expo Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
162000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20607000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2050000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
18557000

Files In Submission

Name View Source Status
0000950170-22-022200-index-headers.html Edgar Link pending
0000950170-22-022200-index.html Edgar Link pending
0000950170-22-022200.txt Edgar Link pending
0000950170-22-022200-xbrl.zip Edgar Link pending
expo-20220930.htm Edgar Link pending
expo-20220930.xsd Edgar Link pending
expo-ex31_1.htm Edgar Link pending
expo-ex31_2.htm Edgar Link pending
expo-ex32_1.htm Edgar Link pending
expo-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
expo-20220930_cal.xml Edgar Link unprocessable
expo-20220930_def.xml Edgar Link unprocessable
expo-20220930_lab.xml Edgar Link unprocessable
expo-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
expo-20220930_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending